Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients: Relationship, with histologic outcome of recurrent hepatitis C

American Journal of Clinical Pathology

Volumn 111, Issue 2, 1999, Pages 252-258

  Costes, Valérie ^a   Durand, Luc ^a   Pageaux, Georges Philippe ^a   Ducos, Jacques ^a   Mondain, Anne Marie ^a   Picot, Marie Christine ^a   Domergue, Jacques ^a   Larrey, Dominique ^a   Baldet, Pierre ^a  

^a NONE

Author keywords

Acute rejection; Disease recurrence; Genotype; Hepatitis C; Liver transplantation; Pathology; RNA

Indexed keywords

ALANINE AMINOTRANSFERASE; RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CELL DEATH; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; NONHUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; RNA ANALYSIS; VIRUS GENE; VIRUS REPLICATION;

EID: 0032924563     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.2.252     Document Type: Article

References (35)

1. Ferrel L, Wright T, Roberts J, et al. Hepatitis C viral infection in liver transplant recipients. Hepatology. 1992;16:865-876.
2. Féray C, Gigou M, Samuel D, et al. The course of hepatitis C infection after liver transplantation. Hepatology. 1994;20:1137-1143.
3. Chazouillères O, Kim M, Ferrel L, et al. Quantification of hepatitis C virus RNA in liver transplant recipients. Gastroenterology. 1994;106:994-999.
4. Féray C, Samuel D, Thiers V, et al. Reinfection of liver graft by hepatitis C virus after liver transplantation. J Clin Invest. 1992;89:1361-1365.
5. Martin P, Munoz S, Di Bisceglie A, et al. Recurrence of hepatitis C virus infection after orthotopic liver transplantation. Hepatology. 1991;13:719-721.
6. Poterucha JJ, Gross JB. Hepatitis C after liver transplantation. Gastroenterology. 1995;108:1314-1317.
7. Gane E, Naoumov N, Qian K, et al. A longitudinal analysis of hepatitis C virus replication following liver transplantation. Gastroenterology. 1996;110:167-177.
8. Simmonds P, Alberti A, Alter H, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321-1324.
9. Féray C, Gigou M, Samuel D, et al. Influence of the genotypes of hepatitis C virus on the severity of recurrent liver disease after liver transplantation. Gastroenterology. 1995;108:1088-1096.
10. Wartell CF, Shuhart M, Gretch D, et al. HCV genotypes and recurrent hepatitis C following liver transplantation [abstract]. Hepatology. 1994;20:247A.
11. Gane E, Portmann B, Naoumov N, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815-820.
12. Belli L, Silini E, Alberti A, et al. HCV genotypes, post transplant hepatitis and HCV recurrence after liver transplantation [abstract]. Hepatology. 1994;20:131A.
13. Arnold J, Muller H, Boeser T, et al. Hepatitis C viral genotypes: association with post-operative course after liver transplantation [abstract]. Hepatology. 1995;22:110A.
14. Boker K, Dalley G, Matthias J, et al. Long-term outcome of hepatitis C virus infection after liver transplantation. Hepatology. 1997;25:203-210.
15. Desmet V, Gerber M, Hoofnagle J, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology. 1994;19:1513-1520.
16. Knodell R, Ishak R, Black W, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981;1:431-435.
17. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658-663.
18. SAS Institute. SAS/STAT Users' Guide, Version 6. Vol 2. 4th ed. Cary, NC: SAS Institute; 1989:846.
19. Terrault NA, Wright TL. Hepatitis C virus in the setting of transplantation. Semin Liver Dis. 1995;15:92-100.
20. Greenson JK, Svoboda-Newman SM, Merion R, et al. Histologic progression of recurrent hepatitis C in liver transplant allografts. Am J Surg Pathol. 1996;20:713-738.
21. Randhawa P, Demetris A. Hepatitis C virus infection in liver allografts. Pathol Annu. 1995;30:203-226.
22. Demetris A, Kakizoe S, Oguma S. Pathology of liver transplantation. In: Williams J, ed. Hepatic Transplantation. Philadelphia, Pa: Saunders; 1990:60-113.
23. Pappo O, Ramos H, Starzl T, et al. Structural integrity and identification of cause of liver allograft dysfunction occuring more than 5 years after transplantation. Am J Surg Pathol. 1995;19:192-206.
24. Demetris A, Seaberg E, Batts K, et al. Chronic liver allograft rejection: a National Institute of Diabetes and Digestive and Kidney Diseases interinstitutional study analyzing the reliability of current criteria and proposal of an expanded definition. Am J Surg Pathol. 1998;22:28-39.
25. Desmet V. Cholestasis: extrahepatic obstruction and secondary biliary cirrhosis. In: MacSween R, Anthony P, Scheuer P, et al, eds. Pathology of the Liver. 3rd ed. New York, NY: Churchill Livingstone; 1994:425-476.
26. Asfar S, Metrakos P, Freyer J, et al. An analysis of late deaths after liver transplantation. Transplantation. 1996;9:1377-1381.
27. Dusheiko G, Schmilovitz-Weiss H, Brown D, et al. Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology. 1994;19:13-18.
28. Dubois F, Desenclos JC, Mariotte N, et al and the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. Hepatology. 1997;25:1490-1496.
29. Pawlotski JM, Roudot-Thoraval F, Bastie A, et al. Are hepatitis C virus genotypes 1a and 1b so different [abstract]? Hepatology. 1995;22:950A.
30. Sheiner P, Schwartz M, Mor E, et al. Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology. 1995;21:30-34.
31. Singh N, Gayowski T, Ndimbie O, et al. Recurrent hepatitis C virus hepatitis in liver transplant recipients receiving tacrolimus: association with rejection and increased immunosuppression after transplantation. Surgery. 1996;119:425-426.
32. Freeman R, Trans S, Lee Y, et al. Serum hepatitis C RNA titers after liver transplantation are not correlated with immunosuppression or hepatitis. Transplantation. 1996;61:542-546.
33. McHutchison J, Wilkes L, Pockros P, et al. Pulse corticosteroid therapy increases viremia (HCV RNA) in patients with chronic HCV infection [abstract]. Hepatology. 1993;18:87A.
34. Gonzalez-Peralta R, Davis G, Lau J. Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection. J Hepatol. 1994;21:255-259.
35. Mondelli M, Alberti A, Tremolada F, et al. In vitro cell mediated cytotoxicity for autologous liver cells in chronic non-A non-B hepatitis. Clin Exp Immunol. 1986;63:147-155.